| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736551 | 6480464 | Ethinyl Estradiol results in increased expression of PPP2R2A mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736551 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R2A mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | affects expression | ISO | RGD:733714 | 6480464 | Estradiol affects the expression of PPP2R2A mRNA | CTD | PMID:22574217 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:733714 | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to PPP2R2A protein] | CTD | PMID:17220478 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | RGD:733714 | 6480464 | Metribolone results in decreased expression of PPP2R2A protein | CTD | PMID:17152098 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736551 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R2A mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PPP2R2A mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PPP2R2A mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:733714 | 6480464 | beta-methylcholine affects the expression of PPP2R2A mRNA | CTD | PMID:21179406 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of PPP2R2A mRNA | CTD | PMID:19162173 |
| aflatoxin B1 | increases expression | ISO | RGD:736551 | 6480464 | Aflatoxin B1 results in increased expression of PPP2R2A mRNA | CTD | PMID:19770486 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PPP2R2A mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736551 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PPP2R2A mRNA | CTD | PMID:21715664 |
| clofibrate | multiple interactions | ISO | RGD:736551 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA; more ... | CTD | PMID:17585979 |
| clozapine | decreases expression | EXP | | 6480464 | Clozapine results in decreased expression of PPP2R2A mRNA | CTD | PMID:15860345 |
| copper(2+) sulfate | increases expression | ISO | RGD:733714 | 6480464 | Copper Sulfate results in increased expression of PPP2R2A mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:733714 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA | CTD | PMID:19167446 |
| cyclosporin A | increases expression | ISO | RGD:733714 | 6480464 | Cyclosporine results in increased expression of PPP2R2A mRNA | CTD | PMID:20106945 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of PPP2R2A mRNA | CTD | PMID:21551480 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of PPP2R2A mRNA | CTD | PMID:17920746 |
| formaldehyde | decreases expression | ISO | RGD:733714 | 6480464 | Formaldehyde results in decreased expression of PPP2R2A mRNA | CTD | PMID:20655997 |
| haloperidol | decreases expression | EXP | | 6480464 | Haloperidol results in decreased expression of PPP2R2A mRNA | CTD | PMID:15860345 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of PPP2R2A mRNA | CTD | PMID:16393664 |
| microcystin-LR | affects expression | EXP | | 6480464 | cyanoginosin LR affects the expression of PPP2R2A protein | CTD | PMID:22000993 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PPP2R2A mRNA | CTD | PMID:20360939 |
| nocodazole | decreases response to substance | ISO | RGD:733714 | 6480464 | PPP2R2A results in decreased susceptibility to Nocodazole | CTD | PMID:17724024 |
| paracetamol | multiple interactions | ISO | RGD:736551 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of PPP2R2A mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:736551 | 6480464 | Acetaminophen affects the expression of PPP2R2A mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:736551 | 6480464 | Paraquat results in increased expression of PPP2R2A mRNA | CTD | PMID:21371552 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PPP2R2A mRNA | CTD | PMID:16221955 |
| phenobarbital | affects expression | ISO | RGD:733714 | 6480464 | Phenobarbital affects the expression of PPP2R2A mRNA | CTD | PMID:19159669 |
| pirinixic acid | increases expression | ISO | RGD:736551 | 6480464 | pirinixic acid results in increased expression of PPP2R2A mRNA | CTD | PMID:18301758 |
| valproic acid | decreases expression | ISO | RGD:736551 | 6480464 | Valproic Acid results in decreased expression of PPP2R2A mRNA | CTD | PMID:21427059 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PPP2R2A protein | CTD | PMID:22689922 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PPP2R2A protein | CTD | PMID:22689922 |